This study showed that high glucose could affect the expression of lncRNA MEG3 and govern the miR-483-3p/ERp29 proteins in HCC patients, suggesting that management of lncRNA MEG3 could be promising for the treatment of HCC patients with diabetes (126). This evidence concerns the gene MEG3 and hepatocellular carcinoma.